Trump can curb the costs of healthcare and save lives – here is how

Among all problems that make up the American health care system, the high cost of pharmaceutical preparations is one of the most common of patients.

The poll finds that most Americans I think the drug is very expensive, They are often right – even if price medications overcome alternatives such as surgery, hospitalization or pain.

President Donald Trump I promised to implement health care reforms Whoever increases innovation and improves the ability to afford costs.

Some see it as contradictory endeavors – but when it comes to pharmaceutical preparations, both the president’s goals can be achieved at the same time.

This week, two of us, along with a team of senior health and economic experts, have launched most of the favorite patients, a working group aimed at developing reforms that reduce the prices of medicines in ways that do not hinder or delay the development of new drugs.

Before we suggest policies that can succeed, let’s be clear about the following: Price controls imposed by the government.

The decrees from top to bottom that remove the profit motivation from drug research and development will cause more harm than their benefit, which hinders the race to determine cancer, Alzheimer’s, Parkinson’s paralysis, epilepsy and other harsh diseases.

It is also a short-sighted solution: it ignores the fact that 93 % of medical prescriptions are for very cheap drugs-in fact, cheaper here from the outside-that appear after innovators earn the necessary returns for their investments.

Instead, let’s try some innovations that make both the doctor and the economy.

First, do easy things first and allow patients to buy medicines directly from pharmaceutical companies.

Our last poll, which was conducted by 1,000 voters in the case of the battlefield, found 86 % enormous support for this concept, which would reduce the prices of medicines by avoiding expensive retail marks imposed by insurance companies and others.

Most voters also prefer Trump’s intention to restrain the expensive mediators like them Director of pharmacy entitlements Industry, which negotiates the prices of drugs for insurance companies.

We must also ask foreign countries to pay their fair share of medical innovations developed in the United States – almost all.

Trump can use his NATO negotiations as a model here: just as he did Europe asks for a dowry More on the benefits of NATO security through the minimum levels of military spending, it can persuade commercial partners to spend more GDP on new drugs.

Currently, more than 70 % of global pharmaceutical profits come from the United States, although we are born less than a quarter of Global GDP.

We will spend 13,000 dollars annually on the individual’s health care, while the rest of the developed world spends much less than $ 10,000-partly because we allow more health care prices in the free market more than other countries.

Trump is already implementing some of these repairs in First trade deals in AmericaObtaining about 300 billion dollars from foreign obligations for new pharmaceutical research and development, investment in manufacturing and transformational materials.

These obligations share the burden of finding treatments that benefit all humanity – while fueling the American research engine that justifies investments.

After that, the Food and Drug Administration must fix the approval of the antique medicine, which is ancient: many potential wonders developed by small biomedical companies when this process is prohibitive and delayed the depletion of their capital.

Food and drug management (FDA) must follow the rapid experimental drugs for broken and deadly diseases, and the “right to try” rules must be accelerated to obtain promising drugs for the people they need.

In addition, we believe that the Food and Drug Administration (FDA) must reduce its regulations and use economic standards, not only clinical standards, to determine whether the drug may be tracked quickly for approval: simply, the cheapest drugs must be allowed to reach the market faster.

Finally, we are confident that the transparency of prices in medicines and all other medical services would help reduce prices and encourage more comparison by patients.

We do not buy food, gas or homes without knowing their price – but this is often the case with medicines, hospitals and medical procedures.

Republicans have lost the political benefits to seize proper reforms like this.

Voters are constantly viewing the Republican Party as the least care and less reliable in resolving health care concerns in our nation.

This made them wander.

They keep their mouths closed and flee from any discussion about the good complaints of voters – and they often lose elections as a result.

As mid -time approaches, Republicans who promote innovation with our most preferred patient proposals will help to reduce costs, ensure vital American medical superiority, and save lives.

Everyone is on that.

Stephen Moore is a co -founder of splendor, where Thomas Phillipson is an older research colleague.